首页 | 本学科首页   官方微博 | 高级检索  
     


The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer
Authors:Rebecca E. Graff  Andreas Pettersson  Rosina T. Lis  Natalie DuPre  Kristina M. Jordahl  Elizabeth Nuttall  Jennifer R. Rider  Michelangelo Fiorentino  Howard D. Sesso  Stacey A. Kenfield  Massimo Loda  Edward L. Giovannucci  Bernard Rosner  Paul L. Nguyen  Christopher J. Sweeney  Lorelei A. Mucci
Affiliation:1. Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts;2. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California;3. Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts;4. Center for Molecular Oncologic Pathology, Dana–Farber Cancer Institute, Boston, Massachusetts;5. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts;6. Pathology Unit, Addarii Institute, S. Orsola‐Malpighi Hospital, Bologna, Italy;7. Department of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts;8. Department of Urology, University of California, San Francisco, San Francisco, California;9. Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts;10. Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts;11. Department of Radiation Oncology, Dana–Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts;12. Lank Center for Genitourinary Oncology, Dana–Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
Abstract:
Keywords:TMPRSS2:ERG  androgen deprivation therapy  prostate cancer  prognosis  gene fusion
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号